Clinical trial
Evolution of Estimated Glomerular Filtration Rate in Chronic Hepatitis C Patients Receiving Sofosbuvir-based or Sofosbuvir-free Direct Acting Antivirals
NCT04047680 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evolution of Estimated Glomerular Filtration Rate in Chronic Hepatitis C Patients Receiving Sofosbuvir-based or Sofosbuvir-free Direct Acting Antivirals
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- June 30, 2019
- Enrollment
- 441 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c, renal disease, viral hepatitis c